Cargando…
Complement Activation in Inflammatory Skin Diseases
The complement system is a fundamental part of the innate immune system, playing a crucial role in host defense against various pathogens, such as bacteria, viruses, and fungi. Activation of complement results in production of several molecules mediating chemotaxis, opsonization, and mast cell degra...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911619/ https://www.ncbi.nlm.nih.gov/pubmed/29713318 http://dx.doi.org/10.3389/fimmu.2018.00639 |
_version_ | 1783316243837616128 |
---|---|
author | Giang, Jenny Seelen, Marc A. J. van Doorn, Martijn B. A. Rissmann, Robert Prens, Errol P. Damman, Jeffrey |
author_facet | Giang, Jenny Seelen, Marc A. J. van Doorn, Martijn B. A. Rissmann, Robert Prens, Errol P. Damman, Jeffrey |
author_sort | Giang, Jenny |
collection | PubMed |
description | The complement system is a fundamental part of the innate immune system, playing a crucial role in host defense against various pathogens, such as bacteria, viruses, and fungi. Activation of complement results in production of several molecules mediating chemotaxis, opsonization, and mast cell degranulation, which can contribute to the elimination of pathogenic organisms and inflammation. Furthermore, the complement system also has regulating properties in inflammatory and immune responses. Complement activity in diseases is rather complex and may involve both aberrant expression of complement and genetic deficiencies of complement components or regulators. The skin represents an active immune organ with complex interactions between cellular components and various mediators. Complement involvement has been associated with several skin diseases, such as psoriasis, lupus erythematosus, cutaneous vasculitis, urticaria, and bullous dermatoses. Several triggers including auto-antibodies and micro-organisms can activate complement, while on the other hand complement deficiencies can contribute to impaired immune complex clearance, leading to disease. This review provides an overview of the role of complement in inflammatory skin diseases and discusses complement factors as potential new targets for therapeutic intervention. |
format | Online Article Text |
id | pubmed-5911619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-59116192018-04-30 Complement Activation in Inflammatory Skin Diseases Giang, Jenny Seelen, Marc A. J. van Doorn, Martijn B. A. Rissmann, Robert Prens, Errol P. Damman, Jeffrey Front Immunol Immunology The complement system is a fundamental part of the innate immune system, playing a crucial role in host defense against various pathogens, such as bacteria, viruses, and fungi. Activation of complement results in production of several molecules mediating chemotaxis, opsonization, and mast cell degranulation, which can contribute to the elimination of pathogenic organisms and inflammation. Furthermore, the complement system also has regulating properties in inflammatory and immune responses. Complement activity in diseases is rather complex and may involve both aberrant expression of complement and genetic deficiencies of complement components or regulators. The skin represents an active immune organ with complex interactions between cellular components and various mediators. Complement involvement has been associated with several skin diseases, such as psoriasis, lupus erythematosus, cutaneous vasculitis, urticaria, and bullous dermatoses. Several triggers including auto-antibodies and micro-organisms can activate complement, while on the other hand complement deficiencies can contribute to impaired immune complex clearance, leading to disease. This review provides an overview of the role of complement in inflammatory skin diseases and discusses complement factors as potential new targets for therapeutic intervention. Frontiers Media S.A. 2018-04-16 /pmc/articles/PMC5911619/ /pubmed/29713318 http://dx.doi.org/10.3389/fimmu.2018.00639 Text en Copyright © 2018 Giang, Seelen, van Doorn, Rissmann, Prens and Damman. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Giang, Jenny Seelen, Marc A. J. van Doorn, Martijn B. A. Rissmann, Robert Prens, Errol P. Damman, Jeffrey Complement Activation in Inflammatory Skin Diseases |
title | Complement Activation in Inflammatory Skin Diseases |
title_full | Complement Activation in Inflammatory Skin Diseases |
title_fullStr | Complement Activation in Inflammatory Skin Diseases |
title_full_unstemmed | Complement Activation in Inflammatory Skin Diseases |
title_short | Complement Activation in Inflammatory Skin Diseases |
title_sort | complement activation in inflammatory skin diseases |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911619/ https://www.ncbi.nlm.nih.gov/pubmed/29713318 http://dx.doi.org/10.3389/fimmu.2018.00639 |
work_keys_str_mv | AT giangjenny complementactivationininflammatoryskindiseases AT seelenmarcaj complementactivationininflammatoryskindiseases AT vandoornmartijnba complementactivationininflammatoryskindiseases AT rissmannrobert complementactivationininflammatoryskindiseases AT prenserrolp complementactivationininflammatoryskindiseases AT dammanjeffrey complementactivationininflammatoryskindiseases |